{"protocolSection":{"identificationModule":{"nctId":"NCT03871309","orgStudyIdInfo":{"id":"005-035-006-ANTR-0607"},"organization":{"fullName":"Rapid Medical","class":"INDUSTRY"},"briefTitle":"Tigertriever Distal Vessels Registry","officialTitle":"Tigertriever Distal Vessels Registry"},"statusModule":{"statusVerifiedDate":"2022-10","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-02-07","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2022-08-04","type":"ACTUAL"},"completionDateStruct":{"date":"2023-10-10","type":"ACTUAL"},"studyFirstSubmitDate":"2019-02-21","studyFirstSubmitQcDate":"2019-03-08","studyFirstPostDateStruct":{"date":"2019-03-12","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-15","lastUpdatePostDateStruct":{"date":"2023-11-18","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Rapid Medical","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"A registry study to collect data on the Tigertriever device at restoring blood flow by removing clots in M2 or distal vessels in patients experiencing acute ischemic stroke, during commercial use.","detailedDescription":"Tigertriever is a CE marked mechanical revascularization device indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset."},"conditionsModule":{"conditions":["Ischemic Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"3 Months","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":9,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Tigertriever","description":"Male or female patients (age ≥18) who present with an acute ischemic stroke due to a M2 or distal (medium to small) vessel occlusion confirmed by vessel imaging and treated with the Tigertriever 17 or 13 revascularization devices.","interventionNames":["Device: Tigertriever"]}],"interventions":[{"type":"DEVICE","name":"Tigertriever","description":"Mechanical Thrombectomy","armGroupLabels":["Tigertriever"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Percentage of participants with Symptomatic Intracranial Hemorrhage (SICH) or new infarct within 24 (±12) hours post-procedure.","description":"Safety Endpoints. SICH shall be defined as Parenchymal Hematoma type 2 coupled with ≥4-point NIHSS deterioration at 24 hours.","timeFrame":"24 hours post procedure"},{"measure":"Percentage of participants with a new occlusion.","description":"Safety Endpoints.","timeFrame":"Day 0 (end of procedure)"},{"measure":"Percentage of participants with a TICI Score ≥IIb post procedure.","description":"Effectiveness Endpoints","timeFrame":"Day 0 (end of procedure)"},{"measure":"Percentage of participants with a TICI Score ≥IIb post procedure after first pass.","description":"Effectiveness Endpoints","timeFrame":"Day 0 (end of procedure)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who present with acute ischemic stroke, who can be treated within 6 hours of symptoms onset, who are either refractory to or ineligible for IV t-PA treatment and intend to be treated with thrombectomy.\n* Patients ≥18\n* NIHSS Score of ≥2\n* Angiographically confirmed occlusion in a M2 or distal (medium to small) branch that is accessible to the Tigertriever device (17 or 13) as determined by the vessel diameter (≥1mm).\n* Anticipated life expectancy of at least 6 months from presentation\n* Signed informed consent form by the patient or a legally acceptable representative.\n\nExclusion Criteria:\n\n* Extended infarct - ischemic changes \\>1/3 MCA territory / 100 ml tissue or ASPECT score \\<5\n\n  * Pre- stroke mRS ≥ 2\n  * Unknown time of stroke symptom onset\n  * Vessel diameter \\< 1mm\n  * Angiographically evident extreme vessel tortuosity that may preclude the device from reaching the target area.\n  * Occlusion/stenosis proximal to thrombus that precludes safe retrieval\n  * Medical co-morbidities including but not limited to:\n  * Uncontrolled coagulopathy such as International Normalized Ratio (INR) of \\> 3.0 or platelets count \\< 40 x109/L or APTT \\>50 sec\n  * Serious concurrent medical illness: myocardial infarction, seizures, sepsis, uncontrolled diabetes, uncontrolled hypertension, brain tumor, renal impairment (eGFR \\<60).\n  * Baseline glucose \\< 2.7 or \\> 22.2 mmol/L\n  * Imaging features of:\n\n    * raised intracranial pressure or significant mass effect (for example, midline shift, severe sulcal effacement, transcompartmental herniation)\n    * intracranial hemorrhage\n    * vascular malformation or aneurysm\n    * significant vascular abnormality such as carotid dissection, complete carotid occlusion or large/medium vessel vasculitis\n  * Allergy/sensitivity to nickel-titanium or contrast media\n  * Females who are pregnant or lactating\n  * Unable to obtain informed consent from the patient or a suitable legal representative\n  * Any other contraindication to thrombectomy","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Male or female patients (age ≥18) who present with an acute ischemic stroke due to a M2 or distal (medium to small) vessel occlusion confirmed by vessel imaging and treated with the Tigertriever 17 or 13 revascularization devices.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Kyri Lobotesis, MD","affiliation":"Imperial College Healthcare","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Imperial College Healthcare","city":"London","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}